• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[食管癌的综合治疗]

[Combined modality treatment of oesophageal cancer].

作者信息

Stahl M, Ruhstaller T

机构信息

Klinik für Internistische Onkologie und Hämatologie, Kliniken Essen-Mitte, Henricistr. 92, 45136 , Essen, Deutschland,

出版信息

Internist (Berl). 2014 Jan;55(1):7-8, 10-4. doi: 10.1007/s00108-013-3315-7.

DOI:10.1007/s00108-013-3315-7
PMID:24154497
Abstract

Oesophageal carcinoma reflects a tumor entity which can be optimally treated with multimodal therapy. Early lymphatic spread and late symptoms lead to mostly advanced tumors at primary diagnosis, which means that they can not be cured by surgery alone. On the other hand these tumors show high sensitivity towards chemo- and radiotherapy. Chemoradiotherapy followed by surgery (trimodal therapy) is considered an international standard of care for operable patients. Definitive chemoradiotherapy or the flexible concept of chemoradiotherapy with optional salvage surgery can be curative options for patients with increased operative risk.

摘要

食管癌是一种可通过多模式治疗实现最佳治疗效果的肿瘤实体。早期淋巴转移和出现较晚的症状导致大多数肿瘤在初次诊断时已处于晚期,这意味着仅靠手术无法治愈。另一方面,这些肿瘤对化疗和放疗表现出高度敏感性。化疗联合放疗后再进行手术(三联疗法)被认为是适合可手术患者的国际标准治疗方案。对于手术风险增加的患者,根治性放化疗或采用灵活的放化疗方案并选择性进行挽救性手术可能是治愈性选择。

相似文献

1
[Combined modality treatment of oesophageal cancer].[食管癌的综合治疗]
Internist (Berl). 2014 Jan;55(1):7-8, 10-4. doi: 10.1007/s00108-013-3315-7.
2
Does cervical lymph node recurrence after oesophagectomy or definitive chemoradiotherapy for thoracic oesophageal squamous cell carcinoma benefit from salvage treatment?对于胸段食管鳞状细胞癌,在食管切除术后或根治性放化疗后发生的颈部淋巴结复发,挽救性治疗是否有益?
Interact Cardiovasc Thorac Surg. 2017 May 1;24(5):792-795. doi: 10.1093/icvts/ivw441.
3
Recurrence Patterns and Long-term Results After Induction Chemotherapy, Chemoradiotherapy, and Curative Surgery in Patients With Locally Advanced Esophageal Cancer.局部晚期食管癌患者诱导化疗、放化疗和根治性手术后的复发模式和长期结果。
Ann Surg. 2019 Jan;269(1):83-87. doi: 10.1097/SLA.0000000000002435.
4
[Multimodal treatment of esophageal carcinoma].[食管癌的多模态治疗]
Dtsch Med Wochenschr. 2014 Oct;139(42):2141-7. doi: 10.1055/s-0034-1370297. Epub 2014 Oct 7.
5
Trimodality therapy and definitive chemoradiotherapy for esophageal cancer: a single-center experience and review of the literature.食管癌的三联疗法和根治性放化疗:单中心经验及文献综述
Dis Esophagus. 2015 Oct;28(7):612-8. doi: 10.1111/dote.12242. Epub 2014 May 27.
6
Salvage esophagectomy after definitive chemotherapy and radiotherapy for advanced esophageal cancer.晚期食管癌在接受确定性化疗和放疗后进行挽救性食管切除术。
Am J Surg. 2004 Sep;188(3):261-6. doi: 10.1016/j.amjsurg.2004.06.003.
7
[Non-metastatic oesophageal cancer: diagnosis and treatment].[非转移性食管癌:诊断与治疗]
Ned Tijdschr Geneeskd. 2019 Sep 13;163:D3718.
8
Chemoradiotherapy followed by surgery versus surgery alone in esophageal cancer patients: is it time for additional evidence?放化疗联合手术对比单纯手术治疗食管癌患者:是否需要更多证据?
World J Surg Oncol. 2011 Apr 19;9:41. doi: 10.1186/1477-7819-9-41.
9
Current and future options for treating esophageal cancer: a paradigm shift toward organ-sparing therapies.食管癌当前及未来的治疗选择:向器官保留疗法的范式转变。
Tex Heart Inst J. 2012;39(6):846-7.
10
Salvage esophagectomy for locoregional failure after chemoradiotherapy in patients with advanced esophageal cancer.放化疗后局部区域复发的晚期食管癌患者行挽救性食管切除术。
Ann Thorac Surg. 2012 Dec;94(6):1862-8. doi: 10.1016/j.athoracsur.2012.07.042. Epub 2012 Sep 7.

引用本文的文献

1
The epidemiology, diagnosis, and treatment of Barrett's carcinoma.巴雷特食管癌的流行病学、诊断与治疗
Dtsch Arztebl Int. 2015 Mar 27;112(13):224-33; quiz 234. doi: 10.3238/arztebl.2015.0224.

本文引用的文献

1
Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus.可切除的胃、胃食管交界部和食管下段腺癌的围手术期化疗(放疗)与初次手术对比
Cochrane Database Syst Rev. 2013 May 31;2013(5):CD008107. doi: 10.1002/14651858.CD008107.pub2.
2
Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial.西妥昔单抗联合或不联合放化疗治疗食管癌患者(SCOPE1):一项多中心、2/3 期随机试验。
Lancet Oncol. 2013 Jun;14(7):627-37. doi: 10.1016/S1470-2045(13)70136-0. Epub 2013 Apr 25.
3
Salvage esophagectomy after failed definitive chemoradiation for esophageal adenocarcinoma.
根治性放化疗失败后的食管腺癌挽救性切除术。
Ann Thorac Surg. 2012 Oct;94(4):1126-32; discussion 1132-3. doi: 10.1016/j.athoracsur.2012.05.106. Epub 2012 Aug 24.
4
Preoperative chemoradiotherapy for esophageal or junctional cancer.术前放化疗治疗食管或食管胃交界癌。
N Engl J Med. 2012 May 31;366(22):2074-84. doi: 10.1056/NEJMoa1112088.
5
Prediction of prognosis after trimodal therapy in patients with locally advanced squamous cell carcinoma of the oesophagus.预测局部晚期食管鳞状细胞癌患者接受三联疗法后的预后。
Eur J Cancer. 2012 Nov;48(16):2977-82. doi: 10.1016/j.ejca.2012.03.010. Epub 2012 Apr 11.
6
Nomograms for prognostication of outcome in patients with esophageal and gastroesophageal carcinoma undergoing definitive chemoradiotherapy.用于预测接受根治性放化疗的食管癌和胃食管交界癌患者结局的列线图。
Oncology. 2012;82(2):108-13. doi: 10.1159/000335951. Epub 2012 Feb 11.
7
Radiotherapy versus surgery within multimodality protocols for esophageal cancer--a meta-analysis of the randomized trials.放疗法与手术联合多模式方案治疗食管癌的疗效比较——随机试验的荟萃分析。
Cancer Treat Rev. 2012 Oct;38(6):599-604. doi: 10.1016/j.ctrv.2011.10.005. Epub 2011 Nov 23.
8
A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907).一项比较术后顺铂联合氟尿嘧啶辅助化疗与术前化疗治疗局部晚期食管鳞状细胞癌(JCOG9907)的随机临床试验。
Ann Surg Oncol. 2012 Jan;19(1):68-74. doi: 10.1245/s10434-011-2049-9. Epub 2011 Aug 31.
9
Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis.可切除食管癌新辅助化疗或放化疗后的生存:更新的荟萃分析。
Lancet Oncol. 2011 Jul;12(7):681-92. doi: 10.1016/S1470-2045(11)70142-5. Epub 2011 Jun 16.
10
Survival from common and rare cancers in Germany in the early 21st century.21 世纪初德国常见和罕见癌症的生存情况。
Ann Oncol. 2012 Feb;23(2):472-9. doi: 10.1093/annonc/mdr131. Epub 2011 May 19.